Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)
A Phase 3, Randomized, Active-Comparator Controlled Clinical Trial to Study the Contraceptive Efficacy and Safety of the MK-8342B (Etonogestrel + 17β-Estradiol) Vaginal Ring and the Levonorgestrel-Ethinyl Estradiol (LNG-EE) 150/30 μg Combined Oral Contraceptive (COC) in Healthy Women 18 Years of Age and Older, at Risk for Pregnancy.
Sponsor: Organon and Co
Terminated
Study terminated by Sponsor as a result of a business decision to discontinue the development program for MK-8342B for reasons unrelated to safety or efficacy.
Other terminated trials from Organon and Co
- Contraception · Phase PHASE3 · Sep 2016
- Dysmenorrhea · Phase PHASE3 · Sep 2016
- Moderate to Severe Primary Dysmenorrhea · Phase PHASE3 · Sep 2016
- Contraception · Phase PHASE3 · Feb 2014
- Dermatitis, Atopic · Phase PHASE4 · May 2010
More terminations from Organon and Co
Other Contraception trials with similar outcome
Listed as NCT02616146, this PHASE3 trial focuses on Contraception and remains terminated or withdrawn. Sponsored by Organon and Co, it has been updated 13 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Terminated PHASE3
-
Mar 2022 — Jun 2024 [monthly]
Terminated PHASE3
▶ Show 8 earlier versions
-
Dec 2021 — Mar 2022 [monthly]
Terminated PHASE3
-
Mar 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Terminated PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE3
-
Feb 2019 — Nov 2020 [monthly]
Terminated PHASE3
-
Jun 2018 — Feb 2019 [monthly]
Terminated PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Dec 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Organon and Co
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Budapest, Hungary , Drammen, Norway , Espoo, Finland , Glostrup Municipality, Denmark , Haar, Germany , Haarlem, Netherlands , Lima, Peru , Mexico City, Mexico , Midrand, South Africa , Rome, Italy and 4 more locations